These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

501 related items for PubMed ID: 25799701

  • 1. B-type natriuretic peptide is a strong independent predictor of long-term outcome after transcatheter aortic valve implantation.
    Gotzmann M, Czauderna A, Aweimer A, Hehnen T, Bösche L, Lind A, Kloppe A, Mügge A, Ewers A.
    J Heart Valve Dis; 2014 Sep; 23(5):537-44. PubMed ID: 25799701
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Elevation of B-Type Natriuretic Peptide at Discharge is Associated With 2-Year Mortality After Transcatheter Aortic Valve Replacement in Patients With Severe Aortic Stenosis: Insights From a Multicenter Prospective OCEAN-TAVI (Optimized Transcatheter Valvular Intervention-Transcatheter Aortic Valve Implantation) Registry.
    Mizutani K, Hara M, Iwata S, Murakami T, Shibata T, Yoshiyama M, Naganuma T, Yamanaka F, Higashimori A, Tada N, Takagi K, Araki M, Ueno H, Tabata M, Shirai S, Watanabe Y, Yamamoto M, Hayashida K.
    J Am Heart Assoc; 2017 Jul 14; 6(7):. PubMed ID: 28710182
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Impact of lung diseases on morbidity and mortality after transcatheter aortic valve implantation: insights from spirometry and body plethysmography.
    Gotzmann M, Knoop H, Ewers A, Mügge A, Walther JW.
    Am Heart J; 2015 Oct 14; 170(4):837-842.e1. PubMed ID: 26386809
    [Abstract] [Full Text] [Related]

  • 9. Different impact of aortic regurgitation assessed by aortic root angiography after transcatheter aortic valve implantation according to baseline left ventricular ejection fraction and N-terminal pro-B-type natriuretic peptide.
    Kaneko H, Hoelschermann F, Schau T, Tambor G, Neuss M, Butter C.
    Cardiovasc Interv Ther; 2018 Jul 14; 33(3):232-238. PubMed ID: 28567700
    [Abstract] [Full Text] [Related]

  • 10. Usefulness of plasma B-type natriuretic peptide in the assessment of disease severity and prediction of outcome after aortic valve replacement in patients with severe aortic stenosis.
    Iwahashi N, Nakatani S, Umemura S, Kimura K, Kitakaze M.
    J Am Soc Echocardiogr; 2011 Sep 14; 24(9):984-91. PubMed ID: 21570253
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Correlation of brain natriuretic peptide levels in patients with severe aortic stenosis undergoing operative valve replacement or percutaneous transcatheter intervention with clinical, echocardiographic, and hemodynamic factors and prognosis.
    Ben-Dor I, Minha S, Barbash IM, Aly O, Dvir D, Deksissa T, Okubagzi P, Torguson R, Lindsay J, Satler LF, Pichard AD, Waksman R.
    Am J Cardiol; 2013 Aug 15; 112(4):574-9. PubMed ID: 23683951
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Long-term prognostic value and serial changes of plasma N-terminal prohormone B-type natriuretic peptide in patients undergoing transcatheter aortic valve implantation.
    Ribeiro HB, Urena M, Le Ven F, Nombela-Franco L, Allende R, Clavel MA, Dahou A, Côté M, Laflamme J, Laflamme L, DeLarochellière H, DeLarochellière R, Doyle D, Dumont E, Bergeron S, Pibarot P, Rodés-Cabau J.
    Am J Cardiol; 2014 Mar 01; 113(5):851-9. PubMed ID: 24528616
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Prognostic value of QRS duration after transcatheter aortic valve implantation for aortic stenosis using the CoreValve.
    Meguro K, Lellouche N, Yamamoto M, Fougeres E, Monin JL, Lim P, Mouillet G, Dubois-Rande JL, Teiger E.
    Am J Cardiol; 2013 Jun 15; 111(12):1778-83. PubMed ID: 23528030
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Predictors of 1-year mortality in patients with aortic regurgitation after transcatheter aortic valve implantation: an analysis from the multicentre German TAVI registry.
    Abdel-Wahab M, Zahn R, Gerckens U, Linke A, Sievert H, Schäfer U, Kahlert P, Hambrecht R, Sack S, Hoffmann E, Senges J, Schneider S, Richardt G, German TAVI Registry Investigators.
    Heart; 2014 Aug 15; 100(16):1250-6. PubMed ID: 24895354
    [Abstract] [Full Text] [Related]

  • 19. Long-Term Outcomes for Patients With Severe Symptomatic Aortic Stenosis Treated With Transcatheter Aortic Valve Implantation.
    Codner P, Orvin K, Assali A, Sharony R, Vaknin-Assa H, Shapira Y, Schwartzenberg S, Bental T, Sagie A, Kornowski R.
    Am J Cardiol; 2015 Nov 01; 116(9):1391-8. PubMed ID: 26342515
    [Abstract] [Full Text] [Related]

  • 20. Prognostic value of serial B-type natriuretic peptide measurement in transcatheter aortic valve replacement (from the PARTNER Trial).
    O'Neill BP, Guerrero M, Thourani VH, Kodali S, Heldman A, Williams M, Xu K, Pichard A, Mack M, Babaliaros V, Herrmann HC, Webb J, Douglas PS, Leon MB, O'Neill WW.
    Am J Cardiol; 2015 May 01; 115(9):1265-72. PubMed ID: 25863422
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.